Company Filing History:
5 out of 1,187 
1 out of 15,475 
Years Active: 2007-2019
Title: Andrew Gale: Innovator in Hemostasis and Cytoprotection
Introduction
Andrew Gale is a prominent inventor based in San Diego, CA, known for his significant contributions to the fields of hemostasis and cytoprotection. With a total of 5 patents, his work focuses on innovative therapies aimed at treating conditions associated with bleeding and hypocoagulation.
Latest Patents
One of Gale's latest patents involves a therapy for the treatment or prevention of conditions associated with bleeding or hypocoagulation. This invention relates to methods that prevent or treat bleeding in individuals, utilizing compositions that include activated protein C (FVa) and FVIIa. The combination of these agents provides a synergistic benefit for patients suffering from genetic disorders like hemophilia or acquired bleeding disorders. Another notable patent features activated protein C variants that maintain normal cytoprotective activity while significantly reducing anticoagulant effects. These variants are designed to treat patients at risk of damage to blood vessels or tissue due to conditions such as severe sepsis or ischemic stroke.
Career Highlights
Gale has worked with esteemed institutions such as The Scripps Research Institute and the University of California. His research has led to groundbreaking advancements in the understanding and treatment of bleeding disorders.
Collaborations
Throughout his career, Andrew Gale has collaborated with notable professionals, including John H. Griffin and Laurent Mosnier. These partnerships have contributed to the development of innovative solutions in the medical field.
Conclusion
Andrew Gale's work exemplifies the impact of innovation in medical therapies, particularly in the treatment of bleeding disorders. His contributions continue to influence the landscape of hemostasis and cytoprotection.